MedLogical Innovations' Grant

MedLogical Innovations raised a round of funding on September 11, 2017. Investors include NSW Ministry of Health.

MedLogical Innovations has developed ProFocal-Rx, a drug that allows prostate cancer patients to have minimally invasive therapy and preserve their prostate gland.…

Articles about MedLogical Innovations' Grant: